Reviva Pharmaceuticals' brilaroxazine shows promise for schizophrenia, but regulatory and financial risks persist. Read why ...

A research team led by Dr Brian Chung Hon-yin (third left) has revealed that individuals who experienced childhood maltreatment face markedly elevated ...

New research from the Institute of Psychiatry, Psychology & Neuroscience, supported by the Population Mental Health ...

By Dennis Thompson HealthDay ReporterMONDAY, Dec. 15, 2025 (HealthDay News) — Most people receiving shock therapy for mental ...

The marijuana industry has sold us a bill of goods, and we’ve given ourselves over to a mass mania, disregarding scientific ...

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

Most people being treated for mental health conditions such as anxiety or depression typically use a mix of just two ...

Next year could be a very different one for stockpickers.Investors have piled into a range of companies with exposure to artificial intelligence this year, helping spawn a boom in a range of ...

A witness with schizophrenia was the reason a prosecutor allowed a man to plead guilty to manslaughter and get only six years ...

Anthony Duncan, an American content creator who survived ‘AI psychosis’, has candidly opened up about the very first signs something was wrong.

Little Foot is a near-complete Australopithecus skeleton — the most complete ever discovered — from South Africa. Researchers ...

At the heart of the cost debate is whether the treatment facility can quickly lower the $562 million that Miami-Dade plans to spend this year on its jail system. By offering supervised residential ...